Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Biocon Limited
Press Release Aug 31 2020
Published Aug 31 2020
4 min read

Press Release Aug 31 2020

Biocon Limited has informed the Exchange regarding a press release dated August 31, 2020, titled "Biocon Biologics and Mylan Announce Launch of Semglee (insulin glargine injection) in the U.S. to Expand Access for Patients Living with Diabetes.".

View Attachment